ArticleJournal of thoracic disease2025
Updated result from the phase 2 PHAROS study: has the sustained efficacy and tolerability of encorafenib plus binimetinib been demonstrated in patients with
Kimio YonesakaPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.